Sort
10,829 grants matching “car t”
Removing and Manipulating Emotional Information in Working Memory: Cognitive and Neural Representations
$770,369Marie Banich · University Of Colorado · R56 · FY2021 · MH
Improving Diabetic Patientsâ Adherence to Treatment and Prevention of Cardiovascular Disease
$769,976Adesuwa B Olomu · Michigan State University · R01 · FY2021 · HL
Precise targeting of T1D specific T cells using CAR and peptide-MHC chimeric antigen ligands
$769,703Wilson Wong · Boston University (Charles River Campus) · R01 · FY2024 · DK
Preclinical development of CM-CX1 for the treatment of ovarian clear cell and renal cell carcinomas
$769,404Joana M Murad · Celdara Medical, Llc · R44 · FY2023 · CA
B cell-dependent anti-tumor immunity in ovarian cancer
$769,358Jose R Conejo-Garcia · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2020 · CA
CAREER: Precision Measurements with Ultracold Diatomic Molecules
$769,000Tanya Zelevinsky · Columbia University · · FY2014 · MPS
IUCRC Phase II: University at Buffalo: Center for Identification Technology Research CITeR
$768,871Venugopal Govindaraju · Suny At Buffalo · · FY2018 · CSE
Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy
$768,857Vladimir Ponomarev · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA
Induction of autophagy to enhance CAR-T cells in HIV cure approaches
$768,446Anjie Zhen · University Of California Los Angeles · R01 · FY2024 · AI
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
$768,331Otto O Yang · University Of California Los Angeles · R01 · FY2023 · AI
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
$768,331Otto O Yang · University Of California Los Angeles · R01 · FY2022 · AI
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
$768,331Otto O Yang · University Of California Los Angeles · R01 · FY2020 · AI
Therapeutic Anti-HIV Chimeric Antigen Receptors Via Stem Cell Delivery
$768,331Otto O Yang · University Of California Los Angeles · R01 · FY2021 · AI
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
$768,221Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2020 · CA
Development of Novel Immunotherapeutic Strategies for Myeloid Malignancies
$767,708Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Comprehensive Interrogation of Toxicity Profiles Associated with Novel CAR T-cell Constructs
$767,708Nirali Shah · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Engineered Immune Cells for T1D
$767,617Everett Meyer · Stanford University · R01 · FY2024 · DK
An Informatics Approach to Preventing Distracted Driving
$767,508Sara Seifert · Minnesota Healthsolutions Corporation · R44 · FY2018 · CE
Neuroprotective Immunity and HIV Dementia
$767,498Howard Eliot Gendelman · University Of Nebraska Medical Center · R01 · FY2023 · NS
Neuroprotective Immunity and HIV Dementia
$767,498Howard Eliot Gendelman · University Of Nebraska Medical Center · R01 · FY2024 · NS
Project 1: Augmenting Regulatory Mechanisms in Protocols of Transient Mixed Chimerism
$767,178Joren C Madsen · Massachusetts General Hospital · P01 · FY2021 · HL
Immunotherapeutic targeting of gangliosides in Ewing Sarcoma
$767,167Robbie G. Majzner · Dana-Farber Cancer Inst · U01 · FY2025 · CA
Computer-Assisted Histologic Evaluation of Cardiac Allograft Rejection
$767,019Kenneth Ber Margulies · University Of Pennsylvania · R01 · FY2023 · HL
Activated NK CAR Cells to Cure HIV
$766,149Pamela J Skinner · University Of Minnesota · R01 · FY2021 · AI
Chemotherapy-free cure of hemoglobin disorders through base editing
$766,048Daniel Evan Bauer · Boston Children'S Hospital · R01 · FY2025 · HL